Rain Therapeutics

Rain Therapeutics

Developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver. Learn more

Launch date
Employees
Market cap
AUD68.0m
Enterprise valuation
(AUD51m) (Public information from Jan 2024)
Fremont California (HQ)
Authorizing premium user...